RT Journal Article
SR Electronic
T1 1386 EVOLVE-106, a T cell engager with integrated CD2 costimulation targeting B7-H4, is a precision therapy for estrogen and Her2 receptor low breast cancers
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A1541
OP A1541
DO 10.1136/jitc-2023-SITC2023.1386
VO 11
IS Suppl 1
A1 Sergeeva, Oksana A
A1 Fearnley, Amber
A1 Zeiger, Jennifer
A1 Tam, Eric M
A1 Sarkar, Mohosin
A1 Lai, Zengzu
A1 Jin, Guixian
A1 Dhindwal, Sonali
A1 Teran, Evelyn
A1 Abulizi, Abudukadier
A1 Sabrin, Afsana
A1 Karp, Hayden
A1 Rodriguez, Julio
A1 Klaskin, Danielle
A1 Lichter, Tracy
A1 Metzler, Kristen
A1 Joinville, Kyla
A1 Martomo, Stella
A1 Matis, Louis
A1 Fine, Jay S
A1 Myers, Jeremy Sh
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A1541.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.